Evonik joint venture expands TAA derivatives capacity in Liaoyang by 50%

Evonik Tianda (Liaoyang) Chemical Additive Co., Ltd. (ETL), a joint venture of Evonik China and NEPC, increased its production capacity for triacetonamine (TAA) derivatives in Liaoyang by 50%. Construction began in 2017 and was completed in March 2018.

“With our new production capacities, we can support the growth of our customers and serve global markets even more effectively.”european-coatings.com

• 1 source
• european-coatings.comEvonik joint venture expands capacity for TAA derivatives in China - European CoatingsApr 4, 2018

Summarized from public sources; check the original articles before acting on it.